These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20919860)

  • 41. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV.
    Connor E; Bagarazzi M; McSherry G; Holland B; Boland M; Denny T; Oleske J
    JAMA; 1991 Apr; 265(13):1693-7. PubMed ID: 1672168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
    Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
    Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia.
    Poulsen A; Demeny AK; Bang Plum C; Gjerum Nielsen K; Schmiegelow K
    Med Pediatr Oncol; 2001 Jul; 37(1):20-3. PubMed ID: 11466718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.
    Struijk GH; Gijsen AF; Yong SL; Zwinderman AH; Geerlings SE; Lettinga KD; van Donselaar-van der Pant KA; ten Berge IJ; Bemelman FJ
    Nephrol Dial Transplant; 2011 Oct; 26(10):3391-8. PubMed ID: 21385859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004.
    Overgaard UM; Helweg-Larsen J
    Scand J Infect Dis; 2007; 39(6-7):589-95. PubMed ID: 17577823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
    Komano Y; Harigai M; Koike R; Sugiyama H; Ogawa J; Saito K; Sekiguchi N; Inoo M; Onishi I; Ohashi H; Amamoto F; Miyata M; Ohtsubo H; Hiramatsu K; Iwamoto M; Minota S; Matsuoka N; Kageyama G; Imaizumi K; Tokuda H; Okochi Y; Kudo K; Tanaka Y; Takeuchi T; Miyasaka N
    Arthritis Rheum; 2009 Mar; 61(3):305-12. PubMed ID: 19248121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
    de Boer MG; Kroon FP; le Cessie S; de Fijter JW; van Dissel JT
    Transpl Infect Dis; 2011 Dec; 13(6):559-69. PubMed ID: 21689251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.
    Lundgren IS; Englund JA; Burroughs LM; Torgerson TR; Skoda-Smith S
    Pediatr Infect Dis J; 2012 Jan; 31(1):95-7. PubMed ID: 21817949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Vananuvat P; Suwannalai P; Sungkanuparph S; Limsuwan T; Ngamjanyaporn P; Janwityanujit S
    Semin Arthritis Rheum; 2011 Dec; 41(3):497-502. PubMed ID: 21959291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumocystis jiroveci pneumonia.
    Luks AM; Neff MJ
    Respir Care; 2007 Jan; 52(1):59-63. PubMed ID: 18330040
    [No Abstract]   [Full Text] [Related]  

  • 52. Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline Review.
    Duarte C; Gilbert D; Sheridan AD; PharmaD SDW; Lam ET
    Oncology (Williston Park); 2020 Mar; 34(3):. PubMed ID: 32212136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pneumocystis pneumonia in newborns: a challenge in contemporary intensive care].
    Kordek A; Kołodziejczyk L; Pawlus B; Łoniewska B; Kuźna-Grygiel W; Rudnicki J
    Ann Acad Med Stetin; 2006; 52(2):65-70; discussion 70. PubMed ID: 17633398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
    Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
    Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
    Green H; Paul M; Vidal L; Leibovici L
    Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A retrospective study of patients with systemic lupus erythematosus combined with Pneumocystis jiroveci pneumonia treated with caspofungin and trimethoprim/sulfamethoxazole.
    Wang ZG; Liu XM; Wang Q; Chen NF; Tong SQ
    Medicine (Baltimore); 2019 Jun; 98(23):e15997. PubMed ID: 31169741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.
    Kosaka M; Ushiki A; Ikuyama Y; Hirai K; Matsuo A; Hachiya T; Hanaoka M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Tojo A; Asano S
    Transpl Infect Dis; 2008 Oct; 10(5):303-7. PubMed ID: 18564982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.
    Iriart X; Challan Belval T; Fillaux J; Esposito L; Lavergne RA; Cardeau-Desangles I; Roques O; Del Bello A; Cointault O; Lavayssière L; Chauvin P; Menard S; Magnaval JF; Cassaing S; Rostaing L; Kamar N; Berry A
    Am J Transplant; 2015 Jan; 15(1):190-9. PubMed ID: 25496195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.